The estimated Net Worth of Brad Vale is at least $1.16 Millón dollars as of 1 March 2021. Brad Vale owns over 5,303 units of Nevro Corp stock worth over $33,116 and over the last 10 years he sold NVRO stock worth over $890,056. In addition, he makes $237,955 as Independent Director at Nevro Corp.
Brad has made over 2 trades of the Nevro Corp stock since 2015, according to the Form 4 filled with the SEC. Most recently he sold 5,303 units of NVRO stock worth $890,056 on 1 March 2021.
The largest trade he's ever made was selling 5,303 units of Nevro Corp stock on 1 March 2021 worth over $890,056. On average, Brad trades about 456 units every 121 days since 2015. As of 1 March 2021 he still owns at least 7,031 units of Nevro Corp stock.
You can see the complete history of Brad Vale stock trades at the bottom of the page.
Dr. Brad H. Vale, Ph.D. D.V.M. is Independent Director of the Company. Dr. Vale was Head of Johnson & Johnson Development Company (“JJDC”), from January 2012 to March 2015. Dr. Vale joined JJDC in March 1992 and was appointed to the position of Vice President, Head of Venture Investments in April 2008. From September 1989 to March 1992, Dr. Vale supported Johnson & Johnson’s medical device businesses at the Corporate Office of Science and Technology as an Executive Director. From 1982 to 1989, he was at Ethicon, Inc., a Johnson & Johnson subsidiary, working on preclinical studies, new business development, and a coronary artery bypass graft internal venture. Dr. Vale currently serves or has served on the board of directors of several private companies, including Neuropace, Inc., Northstar Neuroscience, Inc., CVRx, Inc. and ShiraTronics, Inc. Dr. Vale holds a Ph.D. from Iowa State University, a D.V.M. from Washington State University and a B.S. in Chemistry and Biology from Beloit College. Vale is qualified to serve on our Board due to his investment experience and strategic leadership in the life sciences industry.
As the Independent Director of Nevro Corp, the total compensation of Brad Vale at Nevro Corp is $237,955. There are 17 executives at Nevro Corp getting paid more, with D.Keith Grossman having the highest compensation of $13,877,700.
Brad Vale is 67, he's been the Independent Director of Nevro Corp since 2015. There are 1 older and 23 younger executives at Nevro Corp. The oldest executive at Nevro Corp is Frank Fischer, 78, who is the Independent Director.
Brad's mailing address filed with the SEC is C/O NEVRO CORP., 1800 BRIDGE PARKWAY, REDWOOD CITY, CA, 94065.
Over the last 10 years, insiders at Nevro Corp have traded over $298,472,982 worth of Nevro Corp stock and bought 312,708 units worth $8,709,518 . The most active insiders traders include Ali Behbahani, Holdings A/S Novo y & Johnson Johnson & Johnson.... On average, Nevro Corp executives and independent directors trade stock every 18 days with the average trade being worth of $161,002. The most recent stock trade was executed by Shawn Mc Cormick on 7 June 2023, trading 7,500 units of NVRO stock currently worth $171,600.
headquartered in redwood city, california, nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. nevro has developed and commercialized the senza spinal cord stimulation (scs) system, an evidence-based neuromodulation platform for the treatment of chronic pain. the senza system is the only scs system that delivers nevro's proprietary hf10 therapy. the nevro® senza® scs system received ce mark in 2010, tga approval in 2011, fda approval in 2015, and is commercially available in europe, australia, and the united states.
Nevro Corp executives and other stock owners filed with the SEC include: